Amphastar Pharmaceuticals, Inc. (AMPH) stock forecast — our track record

Lyra published 1 AMPH stock forecast for Amphastar Pharmaceuticals, Inc., with the prediction dated September 2, 2025. It used the short term (0 to 3 months) horizon, and the window ended on December 1, 2025. The forecast was published before the outcome was known. This was Lyra's full closed track record for AMPH in this period.

Overall, the AMPH prediction did not reach its target, but it also was not counted as a miss. It was scored as partial. Targets reached: none. Misses: none. The average success score was 50%. The short-term average score was also 50%, because the only closed forecast used that horizon. The stock rose as much as 2.2% during the scoring window, while Lyra had predicted 25% growth.

The best call and the worst call were the same forecast, since there was only 1 closed AMPH call. On September 2, 2025, Lyra predicted 25% growth over the short term. The stock's peak gain was 2.2%, and the target was not reached. That call received a 50% score. The record was limited, and the single call was a partial result rather than a hit or a miss.